tirzepatide .5 ml Tizaro Injection (Tirzepatide 5 mg/0.5 ml) – JNS Pharma which belongs to a class of drugs known as glucagon Mounjaro® 5mg Vial – Tirzepatide

When you take a GLP-1 medication, you naturally eat less because you feel fuller longer, and food cravings diminish

Omega3s are one of the most researched supplement categories

FDA-approved semaglutide brands and indications Brand Ozempic (injectable) Approval date December 2017 Indication Type 2 diabetes glycemic control Brand Ozempic (injectable) Approval date January 2020 Indication Cardiovascular risk reduction in T2D Brand Rybelsus (oral tablet) Approval date September 2019 Indication Type 2 diabetes (first oral GLP-1) Brand Wegovy (injectable) Approval date June 2021 Indication Chronic weight management (BMI 30 or 27 with comorbidity) Brand Wegovy (injectable) Approval date March 2024 Indication Cardiovascular risk reduction in adults with obesity and CVD Brand Wegovy (injectable) Approval date August 2025 Indication Non-cirrhotic MASH with F2-F3 fibrosis (ESSENCE) Brand Wegovy oral 25 mg pill Approval date December 2025 Indication Chronic weight management (OASIS 4 basis) Brand Ozempic (injectable) Approval date February 2026 Indication CKD progression in T2D (FLOW basis) Research-grade lyophilized semaglutide from supplier sources is not an FDA-approved drug product and is for research use only

Semaglutide is a prescription medication originally developed to manage type 2 diabetes, now FDA-approved for medical weight loss under brand names like Wegovy and Ozempic

Keeping 96% of weight loss on full dose is impressive

Patients with personal or family history of medullary thyroid carcinoma should not take Mounjaro